- Home
- HFFG vs MDXH Comparison
HFFG vs MDXH Comparison
Compare HFFG & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFFG
- MDXH
- Stock Information
- Founded
- HFFG 1997
- MDXH 2003
- Country
- HFFG United States
- MDXH Belgium
- Employees
- HFFG N/A
- MDXH N/A
- Industry
- HFFG Food Distributors
- MDXH
- Sector
- HFFG Consumer Discretionary
- MDXH
- Exchange
- HFFG Nasdaq
- MDXH Nasdaq
- Market Cap
- HFFG 170.5M
- MDXH 141.1M
- IPO Year
- HFFG N/A
- MDXH 2021
- Fundamental
- Price
- HFFG $3.43
- MDXH $3.80
- Analyst Decision
- HFFG
- MDXH Buy
- Analyst Count
- HFFG 0
- MDXH 1
- Target Price
- HFFG N/A
- MDXH $6.00
- AVG Volume (30 Days)
- HFFG 55.3K
- MDXH 163.1K
- Earning Date
- HFFG 11-11-2025
- MDXH 11-05-2025
- Dividend Yield
- HFFG N/A
- MDXH N/A
- EPS Growth
- HFFG N/A
- MDXH N/A
- EPS
- HFFG N/A
- MDXH N/A
- Revenue
- HFFG $1,216,952,000.00
- MDXH $98,953,000.00
- Revenue This Year
- HFFG $4.27
- MDXH $24.77
- Revenue Next Year
- HFFG $4.55
- MDXH $22.21
- P/E Ratio
- HFFG N/A
- MDXH N/A
- Revenue Growth
- HFFG 4.88
- MDXH 22.56
- 52 Week Low
- HFFG $1.70
- MDXH $1.35
- 52 Week High
- HFFG $4.93
- MDXH $3.91
- Technical
- Relative Strength Index (RSI)
- HFFG 56.81
- MDXH 66.39
- Support Level
- HFFG $3.26
- MDXH $3.46
- Resistance Level
- HFFG $3.46
- MDXH $3.80
- Average True Range (ATR)
- HFFG 0.14
- MDXH 0.16
- MACD
- HFFG 0.01
- MDXH -0.01
- Stochastic Oscillator
- HFFG 92.68
- MDXH 76.09
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.